Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 38Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 10Neoplasm Metastasis 7Hodgkin Disease 6Recurrence 4Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Mesothelioma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Carcinoma 2Breast Neoplasms, Male 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Pleural Effusion, Malignant 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non - Small Cell Lung Cancer NSCLC 1Neuroendocrine Tumors 1Neuralgia 1Metatropic dwarfism 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Locally Advanced Non-Small Cell Lung Cancer 1Lethal Congenital Contracture Syndrome 2 1Glioma 1

Interventions

neratinib 3dacomitinib 1Vinorelbine 1TAK-243 1Paclitaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Malignant Solid Tumors × Vinorelbine × Clear all
NCT00958724 2018-06-28

Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors

Puma Biotechnology, Inc.

Phase 1 Completed
6 enrolled 13 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡